Karen Ross. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Angiogenesis Inhibitors/pharmacologyAngiogenesis Inhibitors/therapeutic useCyclosporine/adverse effectsHumansImmunosuppressive Agents/adverse effectsImmunosuppressive Agents/pharmacologyImmunosuppressive Agents/therapeutic useNeoplasms/epidemiologyNeoplasms/etiologyNeoplasms/mortalityNeoplasms/prevention & controlOrgan Transplantation/adverse effectsSarcoma, Kaposi/drug therapySarcoma, Kaposi/etiologySirolimus/pharmacologySirolimus/therapeutic useTacrolimus/adverse effectsUnited States/epidemiology
Substances: See more » Angiogenesis InhibitorsImmunosuppressive AgentsCyclosporineSirolimusTacrolimus
Year: 2007 PMID: 17374827 DOI: 10.1093/jnci/djk141
Source DB: PubMed Journal: J Natl Cancer Inst ISSN: 0027-8874 Impact factor: 13.506